Drug intelligence / Profile preview

rotavirus vaccine + tetanus vaccine + pneumococcal vaccine

Development stage
Unknown
Lead developer
PATH
Modality
Vaccines & Immunotherapeutics
Administration
Oral, Intramuscular
01

Overview

This is a combination of three vaccines administered together—rotavirus vaccine, tetanus vaccine, and pneumococcal vaccine. Each component targets a different pathogen: - **Rotavirus Vaccine** is an oral, live attenuated virus vaccine that induces immunity against rotavirus infection, which causes severe gastroenteritis in infants and young children by stimulating mucosal and systemic immune responses. - **Tetanus Vaccine** is an inactivated toxoid that stimulates the production of antibodies against the tetanus toxin produced by *Clostridium tetani*, preventing the development of tetanus (lockjaw). - **Pneumococcal Vaccine** (usually conjugate or polysaccharide) induces immunity to *Streptococcus pneumoniae*, reducing risk for invasive diseases such as pneumonia, meningitis, and sepsis. The conjugate form uses bacterial polysaccharides linked to a carrier protein (often diphtheria or tetanus toxoid) to enhance immunogenicity. These vaccines are often given as part of routine childhood immunization schedules but are not typically available as a single pre-formulated product; rather, they may be co-administered during the same visit according to recommended schedules[1][3][4]. Each works via antigen-specific immune activation leading to protective antibody formation.

02

Targets

CPS (Streptococcus pneumoniae capsular polysaccharide)

Beyond the preview

Go deeper on rotavirus vaccine + tetanus vaccine + pneumococcal vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rotavirus vaccine + tetanus vaccine + pneumococcal vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call